Phillips-Medisize will Exhibit at RDD 2018

HUDSON, WI – April 20, 2018 – – Phillips-Medisize is a sponsor and exhibitor at this year’s Respiratory Drug Delivery (RDD) conference in Tucson, AZ on April 22-26. RDD offers attendees the unique opportunity to participate in one of the premier international conferences in respiratory drug delivery.

Delivering Connected Health solutions, at scale, isn’t easy. Phillips-Medisize, through its Medicom subsidiary, developed the first FDA approved Connected Health system for a combination drug product. With the integration of Phillips-Medisize, Molex and Medicom, we have both the in-depth experience and manufacturing scale to develop and deploy complete Connected Health solutions, from device to data.

During the conference, individuals will be on hand to demonstrate integrated development and scale-up of respiratory devices, with working, in-market connected devices; low cost connectivity modules; and mobile app development services, including SaMD registration and legal manufacturer. Pulling all of this together is our 3rd Generation Connected Health platform, a secure, open, scalable Cloud platform designed specifically for managing medical data.

Visit Phillips-Medisize at table #2, to talk to our Connected Health and Inhalation experts.

For more information, contact: